BlackRock’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19B | Buy |
2,470,440
+57,823
| +2% | +$29.6M | 0.02% | 610 |
|
|
2025
Q4 | $1.36B | Buy |
2,412,617
+55,494
| +2% | +$31.5M | 0.02% | 557 |
|
|
2025
Q3 | $1.21B | Sell |
2,357,123
-107,567
| -4% | -$47M | 0.02% | 598 |
|
|
2025
Q2 | $774M | Sell |
2,464,690
-223,433
| -8% | -$67.1M | 0.01% | 769 |
|
|
2025
Q1 | $819M | Sell |
2,688,123
-39,134
| -1% | -$13.2M | 0.02% | 721 |
|
|
2024
Q4 | $906M | Buy |
2,727,257
+40,695
| +2% | +$13.8M | 0.02% | 701 |
|
|
2024
Q3 | $897M | Buy |
2,686,562
+108,123
| +4% | +$41.1M | 0.02% | 694 |
|
|
2024
Q2 | $1.06B | Buy |
2,578,439
+85,459
| +3% | +$33.8M | 0.02% | 565 |
|
|
2024
Q1 | $1.01B | Buy |
2,492,980
+74,924
| +3% | +$26.3M | 0.02% | 605 |
|
|
2023
Q4 | $741M | Buy |
2,418,056
+37,943
| +2% | +$10.2M | 0.02% | 735 |
|
|
2023
Q3 | $576M | Sell |
2,380,113
-99,224
| -4% | -$25.4M | 0.02% | 807 |
|
|
2023
Q2 | $595M | Sell |
2,479,337
-702,424
| -22% | -$146M | 0.02% | 821 |
|
|
2023
Q1 | $598M | Buy |
3,181,761
+18,630
| +0.6% | +$3.85M | 0.02% | 800 |
|
|
2022
Q4 | $672M | Buy |
3,163,131
+136,113
| +4% | +$27.2M | 0.02% | 701 |
|
|
2022
Q3 | $476M | Sell |
3,027,018
-388,209
| -11% | -$61.9M | 0.02% | 850 |
|
|
2022
Q2 | $511M | Sell |
3,415,227
-377,467
| -10% | -$54.6M | 0.02% | 835 |
|
|
2022
Q1 | $620M | Buy |
3,792,694
+35,121
| +0.9% | +$5.79M | 0.02% | 815 |
|
|
2021
Q4 | $818M | Buy |
3,757,573
+3,507
| +0.1% | +$734K | 0.02% | 700 |
|
|
2021
Q3 | $711M | Buy |
3,754,066
+37,926
| +1% | +$6.92M | 0.02% | 741 |
|
|
2021
Q2 | $656M | Sell |
3,716,140
-154,008
| -4% | -$26.6M | 0.02% | 828 |
|
|
2021
Q1 | $635M | Buy |
3,870,148
+78,980
| +2% | +$12.1M | 0.02% | 816 |
|
|
2020
Q4 | $528M | Buy |
3,791,168
+185,800
| +5% | +$23.4M | 0.02% | 852 |
|
|
2020
Q3 | $403M | Sell |
3,605,368
-985,805
| -21% | -$114M | 0.01% | 876 |
|
|
2020
Q2 | $427M | Buy |
4,591,173
+51,651
| +1% | +$4.4M | 0.02% | 821 |
|
|
2020
Q1 | $333M | Sell |
4,539,522
-149,593
| -3% | -$13M | 0.02% | 831 |
|
|
2019
Q4 | $394M | Buy |
4,689,115
+91,055
| +2% | +$7.05M | 0.02% | 980 |
|
|
2019
Q3 | $386M | Buy |
4,598,060
+59,455
| +1% | +$4.49M | 0.02% | 934 |
|
|
2019
Q2 | $297M | Buy |
4,538,605
+406,428
| +10% | +$23.4M | 0.01% | 1136 |
|
|
2019
Q1 | $244M | Sell |
4,132,177
-26,182
| -0.6% | -$1.56M | 0.01% | 1261 |
|
|
2018
Q4 | $220M | Buy |
4,158,359
+1,876,296
| +82% | +$103M | 0.01% | 1234 |
|
|
2018
Q3 | $137M | Buy |
2,282,063
+676,396
| +42% | +$37M | 0.01% | 1747 |
|
|
2018
Q2 | $69M | Buy |
1,605,667
+392,792
| +32% | +$15.9M | ﹤0.01% | 2168 |
|
|
2018
Q1 | $42.3M | Buy |
1,212,875
+87,897
| +8% | +$3.21M | ﹤0.01% | 2368 |
|
|
2017
Q4 | $40.8M | Buy |
1,124,978
+648,204
| +136% | +$22.7M | ﹤0.01% | 2412 |
|
|
2017
Q3 | $15.2M | Sell |
476,774
-5,235
| -1% | -$160K | ﹤0.01% | 2941 |
|
|
2017
Q2 | $14M | Sell |
482,009
-105,122
| -18% | -$2.95M | ﹤0.01% | 2990 |
|
|
2017
Q1 | $17.5M | Buy |
587,131
+581,123
| +9,672% | +$18.8M | ﹤0.01% | 2829 |
|
|
2016
Q4 | $217K | Buy |
+6,008
| New | +$200K | ﹤0.01% | 2091 |
|
Other funds holding MEDP
VPM
VCM
WA
BlackRock's MEDP Position: Q1 2026 in Review
BlackRock increased its Medpace (MEDP) stake by 2.4% in Q1 2026, buying an estimated $29.6M and bringing the position to 2,470,440 shares worth $1.19B. The position accounts for 0.02% of the portfolio, ranked #610.
BlackRock first reported a position in MEDP in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.36B in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- BlackRock held 2,470,440 shares of Medpace worth $1.19B as of Q1 2026.
- BlackRock bought 57,823 Medpace shares in Q1 2026, an estimated $29.6M.
- Medpace made up 0.02% of BlackRock's portfolio in Q1 2026, its #610 holding.
- BlackRock first reported a position in Medpace in Q4 2016 and has held it in 38 quarters since.
- BlackRock's Medpace position peaked at $1.36B in Q4 2025.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.